PDS Biotechnology Corporation
PDSB - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$80.37M
Close$
$0.21
85.3% downside
Current Fair Value
85.3% downsideOvervalued by 85.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $80.37 Million |
|---|---|
| Enterprise Value | $-1,152,207,460.00 |
| Earnings per Share | $-0.74 |
| Beta | 1.45 |
| Outstanding Shares | 55,659,669 |
Return
| Return on Equity | 1.01% |
|---|---|
| Return on Assets | -0.41% |
| Return on Invested Capital | 228.54% |
Valuation & Multiples
| P/E Ratio | -2.25 |
|---|---|
| PEG | -67.1 |
| Price to Sales | - |
| Price to Book Ratio | -0.02 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.14 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | -3.79 |
| Debt to Equity | -1.22 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.14
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.19%▼ 13.63% |
|---|---|
| Total Invested | $78,575▼ 98.84% |
| Investors Holding | 6▼ 47.00% |
About PDS Biotechnology Corporation
CEO: Frank Bedu-Addo
Under normal circumstances, the fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities and derivative instruments that provide exposure to equity securities. To gain this exposu...